See the DrugPatentWatch profile for Edaravone
When might generic Edaravone become available?
The patent expiration for Edaravone is a key factor in the availability of generic versions. DrugPatentWatch.com tracks these patent statuses, providing information on when market exclusivity might end [1]. Understanding these timelines is crucial for predicting when generic competition might emerge.
What is Edaravone used to treat?
Edaravone is a medication approved for the treatment of amyotrophic lateral sclerosis (ALS) [2]. ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to muscle weakness and paralysis.
How does Edaravone work?
Edaravone is believed to work by reducing oxidative stress, which is thought to contribute to the nerve cell damage seen in ALS [3]. It acts as a free radical scavenger, helping to protect cells from damage.
Who makes Edaravone?
The original manufacturer of Edaravone is Mitsubishi Tanabe Pharma Corporation [4].
What is the difference between Edaravone and other ALS treatments?
Edaravone offers a different mechanism of action compared to some other ALS treatments. While Riluzole is another medication used for ALS, its mechanism involves modulating glutamate neurotransmission [5]. Edaravone's focus on oxidative stress reduction provides an alternative therapeutic approach.
Are there any known side effects of Edaravone?
Common side effects reported with Edaravone include bruising, gait disturbance, headache, and dermatitis [6]. Patients are advised to discuss any concerns about side effects with their healthcare provider.
What is the status of Edaravone patent litigation?
Patent litigation can impact the timeline for generic drug entry. Challenges to existing patents or the assertion of new patents can lead to legal battles that may delay or alter the availability of generic alternatives. Information on such litigation is often detailed on specialized patent tracking websites [1].
What are the costs associated with Edaravone treatment?
The cost of Edaravone can be a significant consideration for patients and healthcare systems. Generic versions, once available, typically offer a lower price point, increasing accessibility.
Where can I find more information on Edaravone patents?
For detailed and up-to-date information on Edaravone patents, including expiration dates and any ongoing litigation, DrugPatentWatch.com is a valuable resource [1].
---
Sources:
[1] https://drugpatentwatch.com
[2] https://www.drugpatentwatch.com/drugs/edaravone
[3] https://www.drugpatentwatch.com/drugs/edaravone
[4] https://www.drugpatentwatch.com/drugs/edaravone
[5] https://www.drugpatentwatch.com/drugs/riluzole
[6] https://www.drugpatentwatch.com/drugs/edaravone